# Genetically Engineered Hypoimmune Human Muscle Progenitor Cells Can Reduce Immune Rejection

## TL;DR

Scientists engineered muscle cells to avoid immune rejection by modifying proteins that control immune responses and cell survival.

## Contribution

The novelty lies in combining immunomodulatory and anti-apoptotic protein modifications in muscle progenitor cells to enhance transplant survival.

## Key findings

- Editing immunomodulatory proteins reduces recognition by lymphocytes.
- Overexpression of anti-apoptotic proteins helps cells survive the transplant environment.

## Abstract

Cells face two challenges after transplantation: recognition and killing by lymphocytes, and cell apoptosis induced by the transplantation environment. Our hypoimmune cells aim to address these two challenges through editing of immunomodulatory proteins and overexpression of anti‐apoptotic proteins.